Frontlight ResearchEarly access
Active, not recruitingNo phase
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Nice
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 59 people enrolled
- Started
- 19 Oct 2022
- Ended
- 30 Jun 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Non segmental vitiligo
- Health Volunteers
- Record updated
- 4 December 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients with non segmental vitiligo,
- atopic dermatitis, psoriais, alopecia areata,
- 1st degree relative of vitiligo patients
Who cannot take part
- personnal history of other autoimmune disorders,
- segmental or mixed vitiligo,
- oral use of antioxidant,
- pregant women
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To compare the level of circulating functional mitochondria in the serum of vitiligo patients as compared to controls
The 2 groups in the trial
- Vitiligo GroupTreatment being tested
If the subject consents and they meet all the criteria a 20 ml blood sample will be taken.
Treatment: Non segmental vitiligo
- Volunteers GroupOther group
If the subject consents and they meet all the criteria a 20 ml blood sample will be taken.
Treatment: Health Volunteers
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients as Compared to Controls
- Record updated
- 4 December 2024